COGEM Concludes Stacked GM Cotton T304-40 x GHB119 x COT102 Does Not Pose an Environmental Risk in the NetherlandsSeptember 6, 2023
The Netherlands Commission on Genetic Modification (COGEM) released the evaluation of the stacked genetically modified (GM) cotton T304-40 x GHB119 x COT102 for food and feed use, as submitted by Bayer CropScience.
COGEM has previously advised positively on the import and processing of all three GM parental lines of this stacked GM event, as well as on the import and processing of several stacked events of parental lines under assessment, including T304-40 x GHB119.
COGEM is of the opinion that the import and processing of GM cotton T304-40 x GHB119 x COT102 poses a negligible risk to the environment in the Netherlands.
For more information, read the COGEM advice.
You might also like:
- COGEM Concludes Import of Stacked GM Cotton Does Not Pose an Environmental Risk in the Netherlands
- COGEM Concludes Import of MON89034 x 1507 x NK603 Maize Does Not Pose an Environmental Risk in the Netherlands
- Bayer Submits Application for Second Renewal for Import and Processing of GM Maize MON810 in The Netherlands
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- Stakeholders Support Commercial Cultivation of GM Cowpea in Ghana
- Philippines Approves Bt Cotton for Commercial Propagation
- COGEM Concludes Stacked GM Cotton T304-40 x GHB119 x COT102 Does Not Pose an Environmental Risk in the Netherlands
- Best-bet Communication Approaches on New Breeding Technologies Proposed at ABBC2023
- ISAAA and DA-FBC Educated Stakeholders About Mudfish Spawning Technology
- Biotech Company Launches Plant-Based Casein
- Study Highlights Impact of GE Crops in Global Agri Output
- Scientists Map Key Part of SARS-CoV-2 Spike Protein
- Researchers Develop PCR-based Blood Diagnostic Test for Parkinson's Disease
Read the latest:
- Biotech Updates (December 7, 2023)
- Gene Editing Supplement (November 29, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: